baber/WOPTO huggingface dataset:
Patent NZ-530124-A (NZ)
Title: Determination of soil sulphur
Inventor: RAJENDRAM GORDON SHANTHAKUMAR
Filed: 2003-12-11
Abstract: Disclosed is a method of determining the requirement to add sulphur fertiliser to soil, comprising the steps of: (a) obtaining at least one soil sample from a soil to be analysed, (b) measuring the total sulphur concentration in the soil sample or samples, (c) determining whether or not to fertilise the analysed soil by reference to the relationship defined in Figure 2, wherein: i. if the total sulphur concentration is less than 0.06%, sulphur fertiliser should be applied, ii. if the total sulphur concentration is 0.06 to 0.08%, sulphur fertiliser need only be applied if the site is used for dairying applications, iii. if the total sulphur concentration is greater than 0.08%, sulphur fertiliser should not be applied, (d) applying or not applying sulphur fertiliser to the soil as determined by step (c). Also disclosed are methods wherein the easily extractable organic sulphur (EOS) concentration is measured, the whether or not to fertilise the sol is determined by the relationship defined in Figures 1 and 2, wherein: i. if the EOS concentration is less than 20 mg/kg, sulphur fertiliser is applied, ii. if the EOS concentration is between 20 and 25 mg/kg, sulphur need only be applied if the site is used for dairying applications, iii. if the EOS concentration is greater than 25 mg/kg, sulphur should not be applied.
Patent NZ-532071-A (NZ)
Title: Compositions and methods for the modification of gene expression and nucleotides of promoters from Eucalyptus grandis and Pinus radiata
Inventor: PERERA RANJAN
IPC: C07K14/415
Filed: 2000-02-24
Abstract: An isolated polynucleotide comprises the sequence shown in SEQ ID NO:88, a chalcone synthase promoter. DNA constructs comprising the polynucleotides, methods for using such constructs in modulating the gene expression and phenotype of a target organism and plants comprising such constructs are described. (62) Divided out of 525647
Patent NZ-534016-A (NZ)
Title: Triazolo-quinolin derivatives useful as adenosine receptor ligands
Inventor: ARANYI PETER
IPC: C07D471/04
Filed: 2002-12-17
Abstract: Disclosed are compounds of formula (I) and (IA), wherein: R1 is H or alkyl, R2 is H or alkyl, R3 is H, alkyl, or optionally substituted phenyl, thienyl, furyl, R4 and R5 together form an optionally substituted 1,3-butadienyl group, R6 is H, cyano, aminocarbonyl, alkoxycarbonyl or carboxy, R7 is H, alkyl optionally substituted alkylene, phenyl, benzyl, thienyl or furyl, X is -CH2-, -NH-, -NR12-, S, O, sulpho or sulphoxy, n is 0, 1 or 2, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of diseases mediated by the A3 receptor.
Patent NZ-534471-A (NZ)
Title: Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid
Inventor: KOBAYASHI SHIN-ICHIRO
IPC: A61K9/48
Filed: 2003-01-15
Abstract: Disclosed is a pharmaceutical composition which comprises a mixture comprising: a substance selected from the group consisting of 2,2-dichloro-12-(4-chlorophenyl)-dodecanoic acid, a salt thereof, and an ester thereof, and croscarmellose sodium, wherein the croscarmellose sodium acts as a stabilizing agent of the 2,2-dichloro-12-(4-chlorophenyl)-dodecanoic acid, or salt, or ester thereof.
Patent NZ-536058-A (NZ)
Title: Apparatus and method for reprocessing plastics through an extruder comprising an auger, a heater and a nozzle
Inventor: DARBY MATTHEW JOSEPH
IPC: B29C48/52
Filed: 2004-10-20
Abstract: A plastic extruder fro reprocessing solid plastic material is disclosed, wherein the extruder consists, at least in part, of: an auger having an auger blade located inside a closely fitting auger housing for advancing plastic material fed to an inlet portion of the auger to an outlet end of the auger by rotation of the auger blade, the auger blade including a helical screw with a compression portion at which the volume between adjacent turns of the helical screw successively reduces in a direction towards the outlet end of the auger; a heater for heating the solid plastic material, when being advanced by the auger blade through the compression portion, to a temperature at which the solid plastic material converts to a viscous liquid; and an extrusion nozzle connected to the outlet end of the auger and through which the viscous liquid can be extruded.
Patent NZ-538200-A (NZ)
Title: Apparatus for detecting tampering with a utility meter
Inventor: GHOSH KAUSHIK
IPC: G01R11/24
Filed: 2003-08-04
Abstract: An electronic utility meter is disclosed. The meter includes a component (10) for detecting the consumption of a utility, a component (11) for indicating the results of the detection, and a component (20) for detecting the presence of a magnetic field originating outside the meter. The magnetic field detection component (20) includes a detection circuit which includes an inductance (L). The detection component (20) further includes a waveform generator (23) for applying a detection waveform to the detection circuit. An analysing component (20) is provided for monitoring the waveform output for the detection circuit in order to detect the commencement and cessation of a magnetic field originating from outside the meter.
Patent NZ-543995-A (NZ)
Title: Processes for making caralluma extracts and uses
Inventor: RAJENDRAN RAMASWAMY
IPC: A23L33/00
Filed: 2004-05-31
Abstract: Disclosed is a process for producing an extract of plant matter from one or more Caralluma species wherein said process yields an extract comprising substantially the same type and proportions of pregnane glycosides as the original plant matter, said process comprising: one or more extraction steps using at least one solvent or solvent mixture wherein said extraction is performed at a temperature not exceeding 80°C for a time period not exceeding 24 hours; and one or more concentration steps to concentrate the extract until the desired concentration of pregnane glycosides is obtained; wherein the solvent or solvent mixture and the number of concentration steps are selected such as to prevent or minimise the decomposition of said pregnane glycosides and to prevent or minimise the extraction of non-pregnane glycoside matter during said process.
Patent NZ-545842-A (NZ)
Title: Method for operating a wind turbine during a disturbance in the grid
Inventor: WOBBEN ALOYS
IPC: F03D9/00
Filed: 2004-09-22
Abstract: A method of operating a wind power installation, wherein the wind power installation under first operating conditions in a normal operating mode delivers a first power to a connected electrical network, which is proportional to the wind speed, is disclosed. The method comprises the step of controlling the wind power installation in such a way that it remains on the connected electrical network when a disturbance occurs, and delivers a second power to the connected electrical network, which is less than the first power. Under the first operating conditions and upon cessation of the disturbance a third power is delivered to the connected electrical network, where the third power is significantly higher than the first power.
Patent NZ-546119-A (NZ)
Title: Flashing for covering the meter box of a building
Inventor: WELLS TERRY
Filed: 2006-09-10
Abstract: Flashing to prevent the ingress of water and moisture in the area of an external protrusion from a building is disclosed. The flashing (5, 7, 8, 9) is configured to cover a meter box (3) of a building and has a part that is internally mounted behind a cladding of the building.
Patent NZ-547139-A (NZ)
Title: Use of preimplantation factor peptides to treat intolerence to embryo implantation
Inventor: BARNEA EYTAN R
IPC: A61K38/00
Filed: 2004-10-22
Abstract: Disclosed is the use of one or more PIF peptides in the manufacture of a medicament for treating intolerance to embryo implantation in a subject, wherein said medicament is administered to said subject in need thereof. The enhancement of endometrial receptivity can be measured by an increase in beta-3 integrin expression.
Patent NZ-554913-A (NZ)
Title: Methods and compositions for the treatment of central nervous system disorders
Inventor: BENCHERIF MEROUANE
IPC: A61K31/4406
Filed: 2002-12-13
Abstract: Disclosed is a pharmaceutical composition for treatment or prophylaxis of a central nervous system disorder for administration to a subject suffering from the disorder, comprising a compound of formula I that stimulates a nicotine receptor; either or both of at least one inhibitor of the AT2 receptor or at least one inhibitor of a substance that stimulates the AT2 receptor, and a pharmaceutically acceptable carrier.
Patent NZ-561174-A (NZ)
Title: Method for manufacturing a shoe
Inventor: CHUANG-CHUAN CHEN
IPC: B29D35/00
Filed: 2007-09-04
Abstract: A shoe, including a connecting apparatus to connect the vamp and the outsole of the shoe, is disclosed. Included is the use of a vamp, comprising a lateral vamp and a bottom vamp; a connecting medium apparatus, comprising a first plane enclosing the lateral vamp, a second plane connected to the first plane and extending outwards, a third plane connected to the second plane and extending downwards and a fourth plane connected to the third plane and extending inwards, wherein the second plane includes a plurality of holes; and an outsole enclosing the connecting medium apparatus and the bottom vamp, wherein material forming the outsole fills any gap between the fourth plane of the connecting medium apparatus and the bottom vamp, and the holes in the second plane of the connecting medium apparatus.
Patent NZ-563659-A (NZ)
Title: Use of compositions containing omega 3 or 6 fatty acids and either uridine or choline for treating Alzheimer's and other memory disorders
Inventor: WURTMAN RICHARD J
IPC: A61K31/685
Filed: 2006-05-23
Abstract: Disclosed is the use of: (a) an omega-3 fatty acid, an omega-6 fatty acid, or both; and either (b1) uridine, an acyl derivative thereof, a uridine phosphate or a CDP-choline; or (b2) a choline salt; or both (b1) and (b2), to treat Alzheimer's disease, memory impairment or memory loss. The composition increases the synthesis of phospholipids in neural cells and brain cells. Also disclosed is the use of the above composition to treat a memory disorder selected from Pick's disease, Lewy Body disease, Huntington's disease and mild cognitive impairment (MCI).
Patent NZ-563692-A (NZ)
Title: Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one lactic acid salts
Inventor: OKHAMAFE AUGUSTUS
IPC: A61K31/496
Filed: 2006-05-23
Abstract: Disclosed is a crystalline hydrate of a lactic acid salt of 4-amino-5-fluoro-3-[6-(4-methylpiperzin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one, represented by formula I, or a tautomer thereof. Form B of the above mentioned compound is also disclosed with the polymorphic form having an X-ray powder diffraction pattern comprising peaks at 17.6, 19.3 and 26.0 degrees. The method of preparing Form B is also disclosed. Also disclosed is the use of the above mentioned hydrate for the manufacture of a medicament for the treatment of cancer.
Patent NZ-565672-A (NZ)
Title: Efficient coding and decoding of transform blocks
Inventor: SRINIVASAN SRIDHAR
IPC: H04N11/04
Filed: 2006-08-03
Abstract: A digital media decoder comprises a data storage buffer for storing encoded digital media data; and a processor configured to: receive a set of compressed symbols describing a series of transform coefficients; uncompress the symbols; and reconstruct the series of transform coefficients by analysing the set of uncompressed symbols. The set of compressed symbols comprises jointly-coded symbols encoded from a set of code tables according to a context model. Each jointly-coded symbol describes a non-zero level from the series of transform coefficients and whether there are zero-value coefficients following the non-zero level. Also disclosed is a method of encoding a series of transform coefficients for a block representing digital media data comprising using a computing device that implements an encoder, representing the series of transform coefficients as a series of symbols. A given symbol of the series of symbols represents (a) an indication of a non-zero coefficient from the series of transform coefficients and (b) an indication of whether the non-zero coefficient is a last non-zero coefficient for the block and, if not the last non-zero coefficient for the block, an indication of a length of a run of subsequent zero-value coefficients for the block; and for each symbol in the series of symbols, sending the symbol to be encoded in a compressed bit stream. Also disclosed is a method of decoding compressed digital media data comprising receiving a bit stream comprising compressed jointly-coded symbol. Each encoded from a set of code tables according to a context model. The bit stream includes an initial jointly-coded symbol from the jointly coded symbols. The method of decoding further comprises decoding the jointly-coded symbols. The decoding includes decoding the initial jointly-coded symbol to determine a first indication for a run of initial transform coefficient zeros, a second indication for a non-zero transform coefficient level, and third indication for whether the non-zero transform coefficient level is a last non-zero transform coefficient level and, if not, a run of subsequent transform coefficient zeros. The method of decoding further comprises reconstructing a set of transform coefficients from decoded levels and runs of transform coefficient zeros.
Patent NZ-582812-A (NZ)
Title: Apparatus for delivery of pressurised gas
Inventor: BURTON DAVID
IPC: A61M16/00
Filed: 2006-10-16
Abstract: In order to be able to quickly and responsively control the air pressure and flow supplied from the blower via a conduit to the mask of a CPAP system, angular position of the rotor of the blower motor is detected using a single sensor such as a Hall effect sensor, the sensor signal being supplied to a controller which controls the phases of the power signal supplied to the motor. (62) Divided Out of 566721
Patent NZ-592261-A (NZ)
Title: Novel immunotherapy against neuronal and brain tumors
Inventor: SCHOOR OLIVER
IPC: A61K39/00
Filed: 2008-07-25
Abstract: A peptide derived from PTPRZ1 that comprises SEQ ID NO: 5 (KVFGIPTV) and can induce T cells cross-reacting with the peptide. The peptide is able to bind both MHC-I or MHC-II and can stimulate both CD4 and CD8 positive T cells. The peptide can be used for treating glioblastoma.
Patent NZ-595295-A (NZ)
Title: Production of soy protein product using calcium chloride extraction ("s702/s7300/s7200/s7301")
Inventor: MEDINA SARAH
IPC: A23C11/10
Filed: 2010-02-11
Abstract: 595295 A soy protein product having a protein content of at least about 60 wt% (N x 6.25) d.b., preferably a soy protein isolate having a protein content of at least about 90 wt% (N x 6.25) d.b., is prepared from a soy protein source material by extraction of the soy protein source material with an aqueous calcium salt solution, preferably calcium chloride solution, to cause solubilization of soy protein from the protein source and to form an aqueous soy protein solution, separating the aqueous soy protein solution from residual soy protein source, concentrating the aqueous soy protein solution while maintaining the ionic strength substantially constant by using a selective membrane technique, optionally diafiltering the concentrated soy protein solution, and drying the concentrated and optionally diafiltered soy protein solution. Alternatively, the concentrated and optionally diafiltered soy protein solution may be diluted into water to cause the formation of a precipitate, separating the precipitate from the diluting water (supernatant), and drying the separated soy protein solution to form a soy protein product having a protein content of at least about 60 wt% (N x 6.25) d.b., preferably a soy protein isolate having a protein content of at least about 90 wt% (N x 6.25) d.b.. The supernatant may be processed to form soy protein products having a protein content of at least about 60 wt% (N x 6.25) d.b., preferably a soy protein isolate having a protein content of at least 90 wt% (N x 6.25) d.b. Alternatively, the precipitate from the dilution step and diluting water is acidified to resolubilize the precipitate and form a clear soy protein solution. The clear soy protein solution is concentrated while maintaining the ionic strength substantially constant by using a selective membrane technique followed by optional diafiltration and drying.
Patent NZ-599473-A (NZ)
Title: Vertical axis solar powered generator
Inventor: KHORAMIAN MEHRDAD
IPC: H02K7/18
Filed: 2011-01-05
Abstract: An solar power plant 10 includes photovoltaic cells 48 mounted on a central hub 20 beneath a transparent dome 26 and that, when illuminated by sunlight, supply electrical power to motors 36 mounted adjacent the distal ends of arms 28 connected to and rotating the hub plate 22. The motors drive propellers 38 causing the arms and hub to rotate the drive shaft 18 of electric generator 12. The ends of the arms are supported by bearings 34 running on ring races 46, and the propellers, motors, bearings and ring races are covered by ring shaped shrouds 42.
Patent NZ-599934-A (NZ)
Title: Antenna coupler for connecting an RF antenna to a high voltage appliance
Inventor: DREMELJ IGOR
IPC: H01P1/20
Filed: 2010-08-06
Abstract: 599934 Disclosed is an antenna coupler for connection of a radiofrequency antenna to an appliance to which a high voltage can be conductively applied during operation. The antenna includes a multilayer printed-circuit board which has first and second conductor levels, which are electrically isolated from one another in the depth direction of the circuit board. At least one first radio-frequency line (3a, 3b) is included which is coupled to the radio-frequency antenna in the first conductor level and at least one second radio-frequency line (4a, 4b) is coupled on an appliance side, in the second conductor level of the circuit board. The circuit board has an electrically insulating printed-circuit board core layer (6) which has two faces, such that the first and second conductor levels are located on a first face of the two faces. The second radio-frequency line (4a, 4b) is arranged at a greater distance from the printed-circuit board core layer (6) than the first radio-frequency line (3a, 3b) and is arranged on an outer surface of the circuit board. The antenna coupler also has an electrically conductive shielding structure (5), part of which is located on the second opposite face of the two faces of the printed-circuit board core layer (6) and is designed to shield the first radio-frequency line (3a, 3b) against interaction with the carrying of radiofrequency signals. The shielding structure (5) includes a metal surface (9) which partially sheaths the first radiofrequency line (3a, 3b). The second radio-frequency line (4a, 4b) is electrically conductively connected by its outer conductor through the printed-circuit board core layer (6) to the metal surface (9) on the second opposite face of the two faces of the printed-circuit board core layer (6). As a result, the first radio-frequency line (3a, 3b) is isolated against the second radio-frequency line (4a, 4b) and against the metal surface (9).
Patent NZ-631115-A (NZ)
Title: Adjustable hinge
Inventor: PELEKANOS STYLIANOS
IPC: E05D7/06
Filed: 2014-03-03
Abstract: A hinge 1 which includes a first hinge leaf 10, a second hinge leaf 11 and a hinge barrel formed of a pivotally connected and axially aligned first component 2 and second component 3. The first component 2 incorporates a housing 27 that defines an internal recess between a first end and a second end of the first component part. An arm 12 connects the first hinge leaf 10 into the recess through an elongate slot provided in a side of the first component. An adjustment mechanism 18 is housed within the recess to engage the arm and move the first hinge leaf relative to the first component.The adjustment mechanism is coupled to the arm so as to move the arm and adjust the first leaf relative to the first component in a first direction while the first leaf floats relative to the first component in a second direction transverse to the first direction
Patent NZ-704490-A (NZ)
Title: Glycoconjugation processes and compositions
Inventor: GU JIANXIN
IPC: A61P31/04
Filed: 2013-08-12
Abstract: The invention provides eTEC linked glycoconjugates comprising a saccharide covalently conjugated to a carrier protein through a (2-((2-oxoethyl)thio)ethyl)carbamate (eTEC) spacer, immunogenic compositions comprising such glycoconjugates, and methods for the preparation and use of such glycoconjugates and immunogenic compositions.
Patent NZ-716381-A (NZ)
Title: Use of a cd6 binding partner and method based thereon
Inventor: MANIAN BALA S
IPC: C07K16/28
Filed: 2014-07-23
Abstract: Multiple Sclerosis (MS) is an inflammatory autoimmune disorder of the central nervous system (CNS), characterised by inflammatory infiltrates of T-cells, B cells, macrophages and focal demyelinating plaques within the CNS. Both Th1 and Th17 cell-mediated responses have been shown to play a role in the development of inflammatory demyelination. CD6 is an important cell surface protein predominantly expressed by human T cells and a subset of B cells, as well as by some B cell chronic lymphocytic leukemias and neurons. It has been shown that CD6 can function as an important accessory molecule in T cell activation. The present disclosure relates to a method and a use of a CD6 binding partner. In particular, the present disclosure relates to the use of an Itolizumab antibody specifically binding to Domain 1 (D1) of CD6 in the manufacture of a medicament for use in a subject having a stage of multiple sclerosis (MS) that exhibits increased levels of T helper 17 (Th17) cells and having an increased expression of IL-23R, wherein the use in the subject causes a reduction of Th17 cells and a reduction of TNF-alpha, IFN-gamma, IL-6, and IL-17A, and a reduction of expression of IL-23R on one or more of monocytes, T helper cells and natural killer cells in a body fluid of the subject.
Patent NZ-721601-A (NZ)
Title: Improvements in or relating to sonar apparatus
Inventor: CAPUS CHRISTOPHER GLYN
IPC: G01N29/00
Filed: 2014-12-18
Abstract: A method of determining at least part of the structure of an object, the method comprising the steps of providing at least one wideband acoustic signal transmission and reception device, the at least one wideband acoustic signal transmission and reception device being capable of transmitting and receiving one or more wideband acoustic signals, using the at least one wideband acoustic signal transmission and reception device to transmit at least one wideband acoustic signal towards at least a portion of the object, using the at least one wideband acoustic signal transmission and reception device to receive at least one wideband acoustic signal from the object, using the received at least one wideband acoustic signal from the object to create at least one acoustic data set, and analysing the at least one acoustic data set to determine the at least part of the structure of the object.
Patent NZ-731727-A (NZ)
Title: Method for producing a protein hydrolysate
Inventor: LYNGLEV GITTE BUDOLFSEN
IPC: C12P21/06
Filed: 2015-12-01
Abstract: The present invention relates to a method of producing a protein hydrolysate comprising a first step of enzymatic protein hydrolysis performed at a temperature of at least 75°C using a thermostable endopeptidase followed by a second hydrolysis step at a lower temperature using a protein preparation having aminopeptidase activity.